Invesaro

Stocks BLND Financial statements

Financial statements

Blend Labs, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Blend Labs, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2019FY2021FY2021FY2022FY2023FY2024FY2025
Revenue50.796234235110116124
Cost of revenue19.534.311914633.132.532.4
Gross profit31.161.711689.776.583.291.2
Research and development48.655.592.213881.346.132.8
Selling and marketing37.751.484.185.257.534.429.1
General and administrative26.630.112913961.345.750.1
Operating expenses113137313836220132113
Operating income-81.7-75.3-197-746-144-48.8-21.7
Interest expense0011.324.830.86.750
Interest income10.42.411.45.33.7
Other non-operating income0.280.70.494.927.0312.920.9
Pre-tax income-81.4-74.6-208-766-167-42.7-0.88
Income tax0.010.03-38.9-2.240.090.110.25
Net income to minority interests000.77-43.6-1.19-0.07
Net income-81.5-74.6-170-720-179-43.3-6.8
EBITDA-77-71.3-187-735-142-47.5-18.4
EPS, basic-2.49-1.89-1.30-3.28-0.76-0.24-0.10
EPS, diluted-2.49-1.89-1.30-3.28-0.76-0.24-0.10
Shares, basic (weighted)32.839.4132234245254259
Shares, diluted (weighted)32.839.4132234245254259

Balance sheet

FY2019FY2021FY2021FY2022FY2023FY2024FY2025
Cash and equivalents22.641.121312423.53845.1
Short-term investments11133423010656.224.7
Other current assets1.053.282.31.881.541.39
Total current assets18661339617013599.8
Property, plant and equipment4.596.165.743.9511.723
Lease right-of-use assets12.714.711.78.570.341.39
Goodwill02870
Intangible assets1.211732.132.110.08
Other non-current assets0.688.8310.119.221.941.4
Total assets2161,112433206178170
Accounts payable3.446.161.262.171.621.86
Accrued liabilities2.485.83.054.312.125.32
Deferred revenue13.68.078.78.9819.219.4
Total current liabilities356035.531.63939.5
Lease liabilities1414.611.16.9801.22
Other non-current liabilities3.3813.45.482.230.281.57
Total liabilities52.430226917940.441
Total debt021421713800
Paid-in capital511,2181,2871,3221,3281,361
Retained earnings-273-443-1,163-1,342-1,385-1,392
Other comprehensive income-0.01-0.81-0.710.440.60.6
Shareholders' equity135163775123-19.2-56.4-30.5
Total equity135163775123-19.2-56.4-30.5
Total liabilities and equity2161,112433206178170
Shares outstanding0230241250258256

Cash flow statement

FY2019FY2021FY2021FY2022FY2023FY2024FY2025
Net income-81.5-74.6-169-764-180-43.4-6.98
Depreciation and amortization4.763.9910.610.81.521.343.29
Stock-based compensation9.8910.170.811045.627.929
Deferred income tax00-39.3-2.86-0.030.030
Change in payables2.580.291.56-4.91.22-0.290.21
Cash from operations-58.9-65-128-190-128-1311.5
Capital expenditures-0.58-1.31-1.73-2.07-0.04-9.74-11.6
Acquisitions00-40000
Purchases of investments-151-174-352-146-236-102-35.5
Sales and maturities of investments82.413112524731053.246.7
Cash from investing-65.5-7.92-63499.412745.418.5
Debt repaid00-85.1-1450
Stock issued1.654.5125.22.610.271.661.65
Share buybacks-0.05-0.02-0.1300-24.9
Cash from financing13390.89342.22-91-21.1-32.6
Exchange rate effect00-0.01-0.12-0.03-0.010
Net change in cash8.2117.8172-88.9-91.311.3-2.54
Free cash flow-59.5-66.3-129-192-128-22.8-0.08
Interest paid006.4325.127.86.150
Income taxes paid0.010.030.880.280.110.080.39

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.11 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin74.3%Gross profit / revenue.
Operating margin-13.0%Operating income / revenue.
EBITDA margin-9.9%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin1.4%Pre-tax income / revenue.
Net margin-3.3%Net income / revenue.
FCF margin5.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin10.2%Cash from operations / revenue.
Effective tax rate13.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)-3.0%Net income / average total assets.
R&D / revenue26.6%Research and development expense / revenue.
Stock-based pay / revenue22.5%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue4.4%Capital expenditures / revenue.
D&A / revenue3.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y6.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-19.3%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y5.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y9.5%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y0.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y8.1%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-4.5%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-26.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-4.6%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y2.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y3.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y45.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.62xCurrent assets / current liabilities.
Quick ratio0.96x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.96x(Cash + short-term investments) / current liabilities.
Liabilities / assets34.0%Total liabilities / total assets.
Working capital$29.2MCurrent assets - current liabilities.
Tangible book value-$74.4MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.90xRevenue / average total assets.
Fixed asset turnover5.88xRevenue / average property, plant and equipment.
Days payables5 days365 x average accounts payable / cost of revenue.
Capex / operating cash flow42.7%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.02Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.54Revenue / diluted weighted shares.
FCF per share$0.03Free cash flow / diluted weighted shares.
Operating cash flow per share$0.05Cash from operations / diluted weighted shares.
Book value per share-$0.31Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$0.31Tangible book value / shares outstanding.
Cash per share$0.19(Cash + short-term investments) / shares outstanding.
Buybacks / FCF767.7%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$262.5MShare price x shares outstanding.
Enterprise value$217.7MMarket cap + total debt - cash - short-term investments.
P/S2.04xMarket cap / revenue.
P/FCF34.8xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF19.9xMarket cap / cash from operations, when positive.
EV/Sales1.69xEnterprise value / revenue.
EV/FCF28.8xEnterprise value / free cash flow, when both are positive.
FCF yield2.9%Free cash flow / market cap.
Earnings yield-1.6%Net income / market cap (the inverse of P/E).
Shareholder yield22.1%(Dividends paid + share buybacks) / market cap.
What was Blend Labs, Inc.'s revenue in fiscal 2025?

Blend Labs, Inc. reported revenue of $123.6M for fiscal 2025, 6.8% higher than the year before.

Was Blend Labs, Inc. profitable in fiscal 2025?

No. It reported a net loss of $6.8M.

How much free cash flow did Blend Labs, Inc. generate in fiscal 2025?

Cash from operations of $11.5M minus capital expenditures of $11.6M left free cash flow of -$81.0K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Blend Labs, Inc.